.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Advances in Multiple Sclerosis and Experimental Demyelinating Diseases
N/A
€ 196.00
FREE Delivery in Ireland
Description for Advances in Multiple Sclerosis and Experimental Demyelinating Diseases
Hardback. MS affects nearly 400,000 people in the United States, many of whom are between 18 and 40 years of age. With their novel, multifaceted approach to basic science - and their applications in understanding cause and treatment - the authors offer help to clinicians and hope to patients. Series: Current Topics in Microbiology and Immunology. Num Pages: 376 pages, 13 black & white tables, biography. BIC Classification: MJCM. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 25. Weight in Grams: 730.
Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people in the United States. With their novel, multifaceted approach to basic science, the authors of this book offer help to clinicians and hope to patients.
Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people in the United States. With their novel, multifaceted approach to basic science, the authors of this book offer help to clinicians and hope to patients.
Product Details
Format
Hardback
Publication date
2007
Publisher
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Germany
Number of pages
376
Condition
New
Series
Current Topics in Microbiology and Immunology
Number of Pages
362
Place of Publication
Berlin, Germany
ISBN
9783540736769
SKU
V9783540736769
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Advances in Multiple Sclerosis and Experimental Demyelinating Diseases